Despite the indolent clinical presentation and low disease burden, the molecular and cytogenetic findings confirmed the diagnosis of classical APL with <i>TP53</i> loss and <i>ETV6</i> mutation. This evidence concerns the gene TP53 and acute promyelocytic leukemia.